All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
The AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Inhibition of nuclear export is broadly applicable to the field of hemato-oncology. Exportin 1 (XPO1) is the nuclear transporter exporting most tumor suppressor and growth regulatory factors, and is upregulated in many malignancies conferring a poor prognosis. XPO1 inhibition, with selective inhibitors of nuclear transport (SINE), can inhibit proliferation and promote apoptosis.